Lung cancer is a malignant lung tumor characterized by uncontrolle-d cell growth in lung tissues. Most lung carcinomas derive from cancerous bronchia mucosal epithelium cells. The molecular characterization of lung cancer has considerably changed the classification and treatment of these tumors, becoming an essential component of pathologic diagnosis and oncologic therapy decisions.
Here's BT-LAB’s biomarkers for lung cancer
PD-1 PD-L1 __expression__ on tumour cells can guide the use of anti-PD-1/PD-L1 immune modulat-ors to treat patients with non-small cell lung cancer (NSCLC).
You received this e-mail because you purchased something from us, signed up online, dropped a business card at a tradeshow, or signed up with a distributor/partner sometime in the past. We only use your information to send updates about BT-LAB as well as content. Have questions or comments,please send them to: save@bt-laboratory.com or you can Unsubscribe.
